Completed PHASE2 INTERVENTIONAL 2-arm NCT02108119

The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome

Sponsor: Probi AB

Interventions Control placebo Probiotics

Updated 7 times since 2017 Last updated: Jun 15, 2017 Started: May 2, 2014 Primary completion: Nov 30, 2015 Completion: Nov 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Irritable Bowel Syndrome, this trial is completed. The trial is conducted by Probi AB and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jul 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Unknown Status → Completed

▶ Show 2 earlier versions

Jun 2017 — Jul 2017 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2017 — Jun 2017 [monthly]

Recruiting PHASE2

First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Probi AB

Data source: Probi AB

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beek, Netherlands